CYBX Cyberonics, Inc. featured news, full reports, and detailed charts
Cyberonics, Inc. (CYBX) Wrap Up:
Cyberonics, Inc. is a neuromodulation company founded to design, develop and bring to market medical devices that provide a unique therapy, VNS Therapy, for the treatment of epilepsy, TRD and other debilitating neurological or psychiatric diseases and other disorders. VNS Therapy consists of the electrical stimulation of the vagus nerve with an implantable device. Our mission is to improve the lives of people touched by epilepsy, depression and other chronic disorders that may prove to be treatable with our VNS Therapy System. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2007%2f07%2f06%2f0000950129-07-003296.html#FIS_BUSINESS"Cyberonics Inc. (CYBX:NASDAQ)
Snapshot of Cyberonics Inc. (CYBX)
|
OPEN
$17.00
|
PREVIOUS CLOSE
$16.45
|
|
|
DAY HIGH
$17.82
|
DAY LOW
$16.87
|
|
|
52 WEEK HIGH
08/13/09 - $18.29
|
52 WEEK LOW
11/20/08 - $10.31
|
|
|
MARKET CAP
488.5M
|
AVERAGE VOLUME 3 mo
150.8K
|
|
|
DILUTED EPS TTM
$2.33
|
SHARES OUTSTANDING
27.8M
|
|
|
CYBX Does Not Pay Dividends
|
P/E TTM
7.6x
|
|
| K = Thousands M = Millions B = Billions | ||
related news
CYBX Top Compensated Officers
Executives, Board Directors
Key developments for Cyberonics Inc. (CYBX)
Cyberonics Inc., Q2 2010 Earnings Call, Nov-19-2009
Cyberonics Inc. announced that they will report Q2, 2010 results on November 18, 2009.
Cyberonics Inc. held its annual meeting of stockholders on September 24, 2009. As previously disclosed in the company's proxy statement for the Annual Meeting filed on August 6, 2009, in May 2009, on the recommendation of the Nominating & Governance Committee, the company's Board of Directors adopted a resolution reducing the size of Board of Directors from nine members to seven members. After months of studying the size and composition of the Board of Directors, the Nominating & Governance Committee determined that seven directors could effectively execute the Board of Directors' responsibilities at a reduced overall cost to the company. Alan J. Olsen and Michael J. Strauss, the two directors with the longest tenure after Reese S. Terry, Jr., volunteered to leave the Board of Directors effective upon the Annual Meeting.
CYBX Competitors
| Company | Last | Change |
| CNS Response Inc | $1.00 USD | 0.00 |
| Medtronic Inc | $39.62 USD | +0.01 |
| St Jude Medical Inc | $34.32 USD | -0.18 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | CYBX | Industry Range |
| Price/Earnings | 15.0x |
|
| Price/Sales | 3.3x |
|
| Price/Book | 14.0x |
|
| Price/Cash Flow | 15.0x |
|
| TEV/Sales | 2.6x |
|
|
CYBX |
||
CYBX transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||